Effects of Tumor Necrosis Factor on Rat Tumors
Author Information
Author(s): F. Kallinowski, C. Schaefer, G. Tyler, P. Vaupel
Primary Institution: University of Mainz
Hypothesis
How does recombinant human tumor necrosis factor-alpha affect blood flow, oxygen consumption, and growth of isotransplanted rat tumors?
Conclusion
Recombinant human tumor necrosis factor-alpha can stimulate tumor growth at low doses and significantly retard it at higher doses, with effects mediated by changes in tumor perfusion.
Supporting Evidence
- Low doses of TNF increased tumor blood flow and growth.
- High doses of TNF significantly reduced tumor growth and blood flow.
- Changes in oxygen consumption were observed with varying TNF doses.
- Cellular effects included changes in tumor cell size and morphology.
Takeaway
This study shows that a special protein can help or hurt tumor growth depending on how much is used.
Methodology
The study involved Sprague-Dawley rats with implanted DS-carcinosarcoma tumors, treated with varying doses of recombinant human tumor necrosis factor-alpha, and measurements of tumor growth, blood flow, and metabolic changes were taken.
Potential Biases
Potential bias may arise from the specific strain of rats used and the controlled laboratory conditions.
Limitations
The study was limited to a specific type of rat tumor and the effects observed may not be generalizable to all tumor types.
Participant Demographics
Sprague-Dawley rats were used in the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website